The U.S. Food and Drug Administration has issued a report on how the agency communicates the benefits and risks of medical products to health care providers and patients, especially underrepresented populations, including racial subgroups.
FDA has opened a docket to seek public comment on the report's findings and FDA's communication plans going forward.
Please submit electronic or written comments by September 9, 2013.
For more information click the language links below:
In English , 中文 (Chinese), Français (French), Español (Spanish), Tagalog (Tagalog), and Việt (Vietnamese)
FDA has opened a docket to seek public comment on the report's findings and FDA's communication plans going forward.
Please submit electronic or written comments by September 9, 2013.
For more information click the language links below:
In English , 中文 (Chinese), Français (French), Español (Spanish), Tagalog (Tagalog), and Việt (Vietnamese)
No comments:
Post a Comment
The Office of Minority Health and Health Equity (OMHHE) encourages you to add a comment to this discussion. All comments will be moderated and reviewed by OMHHE staff. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. By submitting your comment, you hereby give the OMHHE the right to reproduce or republish comments.
Note: Only a member of this blog may post a comment.